Calendar
event
Ex dividend date
27 Jun 2025
event_available
Last Dividend Payment
01 Jan 1970
About Dermapharm Holding SE
Ticker
info
DMP
Trading on
info
XETRA
ISIN
info
DE000A2GS5D8
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
Dr. Hans-Georg Feldmeier
Headquarters
info
Lil-Dagover-Ring 7, Grünwald, undefined, Germany, 82031
Employees
info
3,610
Website
info
https://ir.dermapharm.de
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Metrics
BasicAdvanced
Market cap
info
€1.81B
P/E ratio
info
16.91
EPS
info
€1.99
Dividend Yield
info
2.65%
Beta
info
1.06
Forward P/E ratio
info
16.45
EBIDTA
info
€257M
Ex dividend date
info
2025-06-27
Price & volume
Market cap
info
€1.81B
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€0.90
Dividend yield
info
2.65%
Forward dividend per share
info
€0.90
Forward dividend yield
info
2.65%
Payout ratio
info
78.33%
Valuation
P/E ratio
info
16.91
Forward P/E
info
16.45
PEG ratio
info
-
Trailing P/E
info
16.91
Price to sales
info
1.84
Price to book
info
3.33
Earnings
EPS
info
€1.99
EPS estimate (current quarter)
info
€0.00
EPS estimate (next quarter)
info
€0.00
EBITDA
info
€257M
Revenues (TTM)
info
€1.19B
Revenues per share (TTM)
info
€22.15
Technicals
Beta
info
1.06
52-week High
info
€41.40
52-week Low
info
€31.70
50-day moving average
info
€32.92
200-day moving average
info
€35.44
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
18.23%
ROA (TTM)
info
6.62%
Profit margin
info
9.00%
Gross profit margin
info
€756M
Operating margin
info
14.20%
Growth
Quarterly earnings growth (YoY)
info
21.90%
Quarterly revenue growth (YoY)
info
-2.90%
Share stats
Outstanding Shares
info
53.8M
Float
info
7.7M
Insiders %
info
77.08%
Institutions %
info
12.24%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
€0.60
-
-
Q3 • 24Beat
€0.38
-
-
Q4 • 24Beat
€0.38
-
-
Q1 • 25Beat
€0.39
-
-
Q2 • 25Beat
€0.77
-
-
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
€272M
€20.9M
7.68%
Q2 • 25
€295M
€41.2M
13.98%
Q3 • 25
8.36%
97.31%
82.08%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
€2.14B
€1.53B
71.65%
Q2 • 25
€2.12B
€1.47B
69.47%
Q3 • 25
-0.87%
-3.88%
-3.04%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
€65.9M
€-9.9M
€-6.6M
€55.5M
Q2 • 25
€44.4M
€-9.8M
€-41.2M
€34.7M
Q3 • 25
-32.57%
-1.19%
520.67%
-37.40%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Dermapharm Holding SE share?
Collapse

Dermapharm Holding SE shares are currently traded for undefined per share.

How many shares does Dermapharm Holding SE have?
Collapse

Dermapharm Holding SE currently has 53.8M shares.

Does Dermapharm Holding SE pay dividends?
Collapse

Yes, Dermapharm Holding SE does pay dividends.

What is Dermapharm Holding SE 52 week high?
Collapse

Dermapharm Holding SE 52 week high is €41.40.

What is Dermapharm Holding SE 52 week low?
Collapse

Dermapharm Holding SE 52 week low is €31.70.

What is the 200-day moving average of Dermapharm Holding SE?
Collapse

Dermapharm Holding SE 200-day moving average is €35.44.

Who is Dermapharm Holding SE CEO?
Collapse

The CEO of Dermapharm Holding SE is Dr. Hans-Georg Feldmeier.

How many employees Dermapharm Holding SE has?
Collapse

Dermapharm Holding SE has 3,610 employees.

What is the market cap of Dermapharm Holding SE?
Collapse

The market cap of Dermapharm Holding SE is €1.81B.

What is the P/E of Dermapharm Holding SE?
Collapse

The current P/E of Dermapharm Holding SE is 16.91.

What is the EPS of Dermapharm Holding SE?
Collapse

The EPS of Dermapharm Holding SE is €1.99.

What is the PEG Ratio of Dermapharm Holding SE?
Collapse

The PEG Ratio of Dermapharm Holding SE is null.